AI VIVO

AI VIVO is a Cambridge biotechnology company combining machine learning and multi-omics data to model disease biology and drug responses.

Its OrganoMaps approach links molecular measurements with tissue and organ-level physiological networks, supporting analysis of therapeutic targets and mechanisms of action.

The company develops computational systems for systems pharmacology and early drug discovery, aiming to inform compound selection and predict biological responses. Its disease models are investigational research tools, not validated clinical diagnostics.